Understanding the symptoms of the common cold and influenza

Ron Eccles, Ron Eccles

Abstract

The common cold and influenza (flu) are the most common syndromes of infection in human beings. These diseases are diagnosed on symptomatology, and treatments are mainly symptomatic, yet our understanding of the mechanisms that generate the familiar symptoms is poor compared with the amount of knowledge available on the molecular biology of the viruses involved. New knowledge of the effects of cytokines in human beings now helps to explain some of the symptoms of colds and flu that were previously in the realm of folklore rather than medicine-eg, fever, anorexia, malaise, chilliness, headache, and muscle aches and pains. The mechanisms of symptoms of sore throat, rhinorrhoea, sneezing, nasal congestion, cough, watery eyes, and sinus pain are discussed, since these mechanisms are not dealt with in any detail in standard medical textbooks.

Figures

Figure 1
Figure 1
Sneezing is mainly triggered by stimulation of trigeminal sensory nerves in the nasal epithelium The trigeminal nerves provide a sensory input to the “sneeze centre” in the medulla that triggers reflex activation of nasal and lacrimal glands to cause a rhinorrhoea, facial muscles to cause closure of the eyes and grimace, and respiratory muscles to cause inspiration followed by an explosive expiration.
Figure 2
Figure 2
Spontaneous changes in unilateral nasal airway resistance recorded in one subject with symptoms of common cold (A), and 6–8 weeks later when healthy (B) Blue symbols represent left nasal airway resistance and red symbols represent right nasal airway resistance. Redrawn from Eccles et al.
Figure 3
Figure 3
Cough is normally caused by aspiration of food or fluid in the airway and this stimulates sensory receptors supplied by the vagus nerve to trigger cough Cough associated with URTIs is caused by a hyper-reactivity of this response, and cough occurs spontaneously. Cough can also be initiated and inhibited by voluntary control, indicating some control of cough from higher centres such as the cerebral cortex.
Figure 4
Figure 4
Fever is caused by cytokines released from macrophages and other immune cells The cytokines may act on vagal nerve endings or enter the brain to cause a resetting of the temperature control centre in the hypothalamus. The hypothalamus causes shivering and constriction of skin blood vessels and also initiates a sensation of chilliness that is perceived at the level of the cerebral cortex. IL=interleukin; TNF=tumour necrosis factor.
Figure 5
Figure 5
Time course of symptoms of sneezing and cough using challenge with infected nasal secretions to infect human volunteers Results redrawn from the study by Jackson et al.

References

    1. Johnston S, Holgate S. Epidemiology of viral respiratory infections. In: Myint S, Taylor-Robinson D, editors. Viral and other infections of the human respiratory tract. Chapman & Hall; London: 1996. pp. 1–38.
    1. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000;160:3243–3247.
    1. Booth CM, Matukas LM, Tomlinson GA. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289:2801–2809.
    1. Kilbourne E. Influenza. Plenum Medical Book Company; New York: 1987. Influenza in man; pp. 157–218.
    1. Heikkinen T, Jarvinen A. The common cold. Lancet. 2003;361:51–59.
    1. Zambon MC, Stockton JD, Clewley JP, Fleming DM. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet. 2001;358:1410–1416.
    1. Jackson G, Dowling H, Spiesman I, Boand A. Transmission of the common cold to volunteers under controlled conditions. 1 The common cold as a clinical entity. Arch Intern Med. 1958;101:267–278.
    1. Tyrrell DA, Cohen S, Schlarb JE. Signs and symptoms in common colds. Epidemiol Infect. 1993;111:143–156.
    1. Turner RB. Epidemiology, pathogenesis, and treatment of the common cold. Ann Allergy Asthma Immunol. 1997;78:531–539.
    1. Hendley JO. The host response, not the virus, causes the symptoms of the common cold: comment. Clin Infect Dis. 1998;26:847–848.
    1. Winther B, Farr B, Turner RB, Hendley JO, Gwaltney JM, Jr, Mygind N. Histopathologic examination and enumeration of polymorphonuclear leukocytes in the nasal mucosa during experimental rhinovirus colds. Acta Otolaryngol. 1984;413(Suppl):19–24.
    1. Beutler B. Science review: key inflammatory and stress pathways in critical illness—the central role of the Toll-like receptors. Crit Care. 2003;7:39–46.
    1. Exton MS. Infection-induced anorexia: active host defence strategy. Appetite. 1997;29:369–383.
    1. Eccles R. Pathophysiology of nasal symptoms. Am J Rhinol. 2000;14:335–338.
    1. Proud D, Reynolds CJ, Lacapra S, Kagey-Sobotka A, Lichenstein LM, Naclerio RM. Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis. 1988;173:613–616.
    1. Shibayama Y, Skoner D, Suehiro S, Konishi JE, Fireman P, Kaplan AP. Bradykinin levels during experimental nasal infection with rhinovirus and attenuated influenza virus. Immunopharmacology. 1996;33:311–313.
    1. Conti B, Tabarean I, Andrei C, Bartfai T. Cytokines and fever. Front Biosci. 2004;9:143–149.
    1. Winther B, Gwaltney JM, Mygind N, Turner RB, Hendley O. Sites of rhinovirus recovery after point innoculation of the upper airway. JAMA. 1986;256:1763–1767.
    1. Rees GL, Eccles R. Sore throat following nasal and oropharyngeal bradykinin challenge. Acta Otolaryngol. 1994;114:311–314.
    1. Georgitis JW. Nasopharyngitis, pharyngitis, and tonsillitis. Immunol Allergy Clin North Am. 1993;13:109–118.
    1. Leung AKC, Robson WLM. Sneezing. J Otolaryngol. 1994;23:125–129.
    1. Eccles R. Upper airway reflexes and involvement of the lower airway. In: Corren J, Togias A, Bousquet J, editors. Upper and lower respiratory disease. Marcel Dekker; New York: 2003. pp. 87–103.
    1. Mygind N, Secher C, Kirkegaard J. Role of histamine and antihistamines in the nose. Eur J Respir Dis Suppl. 1983;128:16–20.
    1. Whitman BW, Packer RJ. The photic sneeze: literature review and discussion. Neurology. 1993;43:868–871.
    1. Hayden FG, Diamond L, Wood PB, Korts DC, Wecker MT. Effectiveness and safety of intranasal ipratropium bromide in common colds. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1996;125:89–97.
    1. Eccles R, Vancauwenberge P, Tetzloff W, Borum P. A clinical study to evaluate the efficacy of the antihistamine doxylamine succinate In the relief of runny nose and sneezing associated with upper respiratory-tract infection. J Pharm Pharmacol. 1995;47:990–993.
    1. Eccles R. Physiology of nasal secretion. Eur J Respir Dis. 1983;62:115–119.
    1. Akerlund A, Greiff L, Andersson M, Bende M, Alkner U, Persson CG. Mucosal exudation of fibrinogen in coronavirus-induced common colds. Acta Otolaryngol. 1993;113:642–648.
    1. Murray S, Del Mar C, O'Rourke P. Predictors of an antibiotic prescription by GPs for respiratory tract infections: a pilot. Fam Pract. 2000;17:386–388.
    1. Stockley RA, Bayley D, Hill SL, Hill AT, Crooks S, Campbell EJ. Assessment of airway neutrophils by sputum colour: correlation with airways inflammation. Thorax. 2001;56:366–372.
    1. Widdicombe J. Microvascular anatomy of the nose. Allergy. 1997;52:7–11.
    1. Eccles R. Anatomy and physiology of the nose and control of nasal airflow. In: Adkinson N, Bochner B, Yunginger J, Holgate S, Busse W, Simons F, editors. Middleton's allergy, principles and practice. 6th edn. Mosby; Philadelphia: 2003. pp. 775–787.
    1. Eccles R. Nasal airflow in health and disease. Acta Otolaryngol. 2000;120:580–595.
    1. Eccles R, Reilly M, Eccles KSJ. Changes in the amplitude of the nasal cycle associated with symptoms of acute upper respiratory tract infection. Acta Otolaryngol. 1996;116:77–81.
    1. Gwaltney JM, Phillips CD, Miller RD, Riker DK. Computed tomographic study of the common cold. N Engl J Med. 1994;330:25–30.
    1. Falck B, Svanholm H, Aust R, Backlund L. The relationship between body posture and pressure in occluded maxillary sinus of man. Rhinology. 1989;27:161–167.
    1. Whittet HB. Infraorbital nerve dehiscence: the anatomic cause of maxillary sinus “vacuum headache”? Otolaryngol Head Neck Surg. 1992;107:21–28.
    1. Kubba H, Robson AK, Bearn MA. Epiphora: the role of rhinitis. Am J Rhinol. 1998;12:273–274.
    1. Annamalai S, Kumar NA, Madkour MB, Sivakumar S, Kubba H. An association between acquired epiphora and the signs and symptoms of chronic rhinosinusitis: a prospective case-control study. Am J Rhinol. 2003;17:111–114.
    1. Maini R, MacEwen CJ, Young JD. The natural history of epiphora in childhood. Eye. 1998;12:669–671.
    1. Ayub M, Thale AB, Hedderich J, Tillmann BN, Paulsen FP. The cavernous body of the human efferent tear ducts contributes to regulation of tear outflow. Invest Ophthalmol Vis Sci. 2003;44:4900–4907.
    1. Paulsen F, Hallmann U, Paulsen J, Thale A. Innervation of the cavernous body of the human efferent tear ducts and function in tear outflow mechanism. J Anat. 2000;197:177–187.
    1. Jones BF, Stewart MA. Duration of cough in acute upper respiratory tract infections. Aust Fam Physician. 2002;31:971–973.
    1. Morice AH. Epidemiology of cough. Pulm Pharmacol Ther. 2002;15:253–259.
    1. Widdicombe JG. Neurophysiology of the cough reflex. Eur Resp J. 1995;8:1103–1202.
    1. Jacoby DB. Pathophysiology of airway viral infections. Pulm Pharmacol Ther. 2004;17:333–336.
    1. Eccles R, Lee PC. Cough induced by airway vibration as a model of airway hyperreactivity in patients with acute upper respiratory tract infection. Pulm Pharmacol Ther. 2004;17:337–342.
    1. Lee P, Cotterill-Jones C, Eccles R. Voluntary control of cough. Pulm Pharmacol Ther. 2002;15:317–320.
    1. Eccles R, Loose I, Jawad M, Nyman L. Effects of acetylsalicylic acid on sore throat pain and other pain symptoms associated with acute upper respiratory tract infection. Pain Med. 2003;4:118–124.
    1. Smith RS. The cytokine theory of headache. Med Hypotheses. 1992;39:168–174.
    1. Gold R, Rieckmann P, Chang P, Abdalla J. The long-term safety and tolerability of high-dose interferon beta-1a in relapsing-remitting multiple sclerosis: 4-year data from the PRISMS study. Eur J Neurol. 2005;12:649–656.
    1. van Zonneveld M, Flink HJ, Verhey E. The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation. Aliment Pharmacol Ther. 2005;21:1163–1171.
    1. Guieu JD, Hellon RF. The chill sensation in fever. Pflugers Arch. 1980;384:103–104.
    1. Cabanac M. Phylogeny of fever. In: Bligh J, Voigt K, editors. Thermoreception and temperature regulation. Springer-Verlag; Berlin: 1990. pp. 284–296.
    1. Leon LR. Invited review: cytokine regulation of fever: studies using gene knockout mice. J Appl Physiol. 2002;92:2648–2655.
    1. Netea MG, Kullberg BJ, Van der Meer JW. Circulating cytokines as mediators of fever. Clin Infect Dis. 2000;31(suppl 5):S178–S184.
    1. Mahoney T, Ball P. Common respiratory tract infections as psychological entities: A review of the mood and performance effects of being ill. Aust Psychol. 2002;37:86–94.
    1. Smith A, Thomas M, Kent J, Nicholson K. Effects of the common cold on mood and performance. Psychoneuroendocrinology. 1998;23:733–739.
    1. Schaefer M, Schmidt F, Neumer R, Scholler G, Schwarz M. Interferon-alpha, cytokines and possible implications for mood disorders. Bipolar Disord. 2002;4(suppl 1):111–113.
    1. Capuron L, Miller AH. Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry. 2004;56:819–824.
    1. Helman CG. “Feed a cold, starve a fever” Folk models of infection in an English suburban community, and their relation to medical treatment. Cult Med Psychiatry. 1978;2:107–137.
    1. Langhans W. Anorexia of infection: current prospects. Nutrition. 2000;16:996–1005.
    1. Baracos V, Rodemann HP, Dinarello CA, Goldberg AL. Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. N Engl J Med. 1983;308:553–558.
    1. Kotler DP. Cachexia. Ann Intern Med. 2000;133:622–634.
    1. Ferreira SH. Prostaglandins, pain, and inflammation. Agents Actions Suppl. 1986;19:91–98.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere